Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Multiple Sclerosis

Free Subscription 23.12.2018 1 BMC Neurol 2 Brain 1 J Neuroimmunol 1 J Neurol 1 J Neurol Neurosurg Psychiatry 1 Lancet Neurol 5 Mult Scler 1 Neurol Clin Pract

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

BMC Neurol

1. FENU G, Fronza M, Lorefice L, Arru M, et al
   Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers.
   BMC Neurol. 2018;18:212.
   PubMed     Text format     Abstract available
   
   

   
   Brain

2. KAUNZNER UW, Kang Y, Zhang S, Morris E, et al
   Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.
   Brain. 2018 Dec 15. pii: 5250435. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
3. VON ESSEN MR, Ammitzboll C, Hansen RH, Petersen ERS, et al
   Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis.
   Brain. 2018 Dec 17. pii: 5250831. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   J Neuroimmunol

4. YOUSEFI F, Lavi Arab F, Saeidi K, Amiri H, et al
   Various strategies to improve efficacy of stem cell transplantation in multiple sclerosis: Focus on mesenchymal stem cells and neuroprotection.
   J Neuroimmunol. 2018;328:20-34.
   PubMed     Text format     Abstract available
   
   

   
   J Neurol

5. STAMPANONI BASSI M, Iezzi E, Landi D, Monteleone F, et al
   Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course.
   J Neurol. 2018;265:2540-2547.
   PubMed     Text format     Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

6. FAKIH R, Diaz-Cruz C, Chua AS, Gonzalez C, et al
   Food allergies are associated with increased disease activity in multiple sclerosis.
   J Neurol Neurosurg Psychiatry. 2018 Dec 18. pii: jnnp-2018-319301.
   PubMed     Text format     Abstract available
   
   

   
   Lancet Neurol

7. CICCARELLI O
   Multiple sclerosis in 2018: new therapies and biomarkers.
   Lancet Neurol. 2019;18:10-12.
   PubMed     Text format    
   
   

   
   Mult Scler

8. HOGEL H, Rissanen E, Barro C, Matilainen M, et al
   Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity.
   Mult Scler. 2018 Dec 20:1352458518819380. doi: 10.1177/1352458518819380.
   PubMed     Text format     Abstract available
   
   
9. SATCHIDANAND N, Drake A, Smerbeck A, Hojnacki D, et al
   Dalfampridine benefits ambulation but not cognition in multiple sclerosis.
   Mult Scler. 2018 Dec 19:1352458518815795. doi: 10.1177/1352458518815795.
   PubMed     Text format     Abstract available
   
   
10. ELLIOTT C, Wolinsky JS, Hauser SL, Kappos L, et al
    Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.
    Mult Scler. 2018 Dec 19:1352458518814117. doi: 10.1177/1352458518814117.
    PubMed     Text format     Abstract available
    
    
11. MATTHEWS L
    Clinical commentary on 'Relapsing remitting multiple sclerosis in progressive external ophthalmoplegia: A report of two cases'.
    Mult Scler. 2018 Dec 17:1352458518816621. doi: 10.1177/1352458518816621.
    PubMed     Text format    
    
    
12. PATEL KR, Karaa A, Mateen FJ
    Relapsing remitting multiple sclerosis in progressive external ophthalmoplegia: A report of two cases.
    Mult Scler. 2018 Dec 17:1352458518800794. doi: 10.1177/1352458518800794.
    PubMed     Text format     Abstract available
    
    

    
    Neurol Clin Pract

13. SCELFO C, Chaudhry S, Hainline C, Peeler C, et al
    Isolated third nerve palsies as the initial manifestation of multiple sclerosis.
    Neurol Clin Pract. 2018;8:e28-e30.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: